GABA Supplement Market

GABA Supplement Market Outlook (2024 to 2034)

Worldwide revenue from the GABA supplement market is poised to reach US$ 51.2 million in 2024 and is forecast to increase at a CAGR of 5.8% to climb to US$ 90.2 million by 2034-end.

GABA (gamma-aminobutyric acid) is a neurotransmitter found in the central nervous system responsible for regulating brain activity and inducing relaxation. These supplements are commonly advertised for their ability to alleviate stress, and anxiety and improve sleep by enhancing GABA levels in the brain.

Key Market Growth Drivers

• Growing awareness about mental health and the significance of GABA in stress reduction and relaxation is fueling the demand for GABA supplements among consumers.

• Modern lifestyles characterized by heightened stress levels, anxiety, and sleep disturbances are driving the interest in supplements that can help manage these conditions, with GABA supplements being particularly sought after for their potential calming effects on the nervous system.

• Increasing number of people suffering from anxiety disorders, insomnia, and other sleep-related problems is driving up demand for natural solutions like GABA supplements to reduce symptoms and improve the quality of sleep.

• These supplements reduce muscle pain and allow the body to rest, thus improving sleep quality. These factors are essential for recovery and enhancement and are becoming more popular among athletes and fitness enthusiasts.

• GABA supplements are being recognized for their potential to assist mood regulation and cognitive performance, particularly in older people, because as the population ages, mental health becomes essential.

• Preferences for natural remedies and holistic approaches to health are driving the demand for GABA supplements as perceived natural alternatives to pharmaceutical drugs for stress and anxiety management.

• Rising availability of GABA supplements in various forms and the ongoing scientific research and clinical studies on their benefits are contributing to increased consumer confidence and interest in these products across different demographics and preferences.

Report Attributes	Details
GABA Supplement Market Size (2024E)	US$ 51.2 Million
Forecasted Market Value (2034F)	US$ 90.2 Million
Global Market Growth Rate (2024 to 2034)	5.8% CAGR
North America Market Value (2024E)	US$ 13.1 Million
East Asia Market Value (2024E)	US$ 11 Million
Sales of Gummies (2024E)	US$ 28 Million
Key Companies Profiled	Now Foods Horbaach Pure Encapsulations Thorne Vitanica Nutrabio Country Life Integrative Therapeutics

Which GABA Supplement Market Trends Should Manufacturers Focus On?

“Rising Awareness about Maintaining Mental Health and Prevalence of Stress-related Disorders”

Increasing consumer awareness, changing lifestyles, a rise in stress-related issues, and the availability of GABA supplements in a variety of forms are key drivers for sales of GABA supplements. Consumer awareness about mental well-being and the benefits of GABA in fostering relaxation and reducing stress and anxiety is increasing, prompting many consumers to think about GABA supplements as a possible option.

The growing need for supplements to treat stress, anxiety, and sleep disorders is derived from modern lifestyles due to high-stress levels. GABA supplements are becoming a popular choice for people looking for natural ways to relieve stress and anxiety, owing to their reputation for relaxing the nervous system. Increasing rates of anxiety, insomnia, and other sleep-related problems among many people have prompted consumers to look for natural remedies, such as GABA supplements, to improve sleep and reduce symptoms. GABA supplements are also used by athletes and fitness enthusiasts to relieve muscle tension, improve sleep quality, and facilitate recuperation after exercise.

The aging population's increasing emphasis on mental well-being and cognitive health has further propelled the GABA supplement market share. These products are acknowledged for their potential to bolster cognitive function and mood stability, especially among older individuals.

What are the Challenges that GABA Supplement Providers Face?

“Insufficient Scientific Evidence to Support Effectiveness and Safety of GABA Supplements”

GABA supplements undergo regulatory scrutiny due to safety, efficacy, and marketing concerns. Regulatory bodies enforce restrictions or demand substantial evidence to substantiate health claims associated with GABA supplements. Some consumers exhibit skepticism regarding the purported benefits of GABA supplements, especially without conclusive scientific validation. This skepticism is leading to a reluctance to purchase GABA supplements, impacting overall sales.

GABA supplements encounter competition from pharmaceutical drugs prescribed for anxiety, stress, and sleep disorders. Pharmaceutical alternatives are perceived as more potent or dependable, challenging the market position of GABA supplements.

Country-wise Insights

Why are Manufacturers of GABA Supplements Interested in the United States?

“Constantly Rising Demand for Antidepressant Medications”

Attribute	United States
Market Value (2024E)	US$ 10.4 Million
Growth Rate (2024 to 2034)	6.1% CAGR
Projected Value (2034F)	US$ 18.8 Million

Depression is prevalent among millions of adults in the United States, resulting in a substantial demand for antidepressant medications. Healthcare providers adhere to clinical guidelines recommending antidepressants as either primary or adjunctive therapy for depression and related mood disorders. Pharmaceutical companies are investing in research and development to enhance the efficacy, tolerability, and safety profiles of antidepressant medications, thus contributing to the expansion of the GABA supplement market size.

Increased awareness and education about mental health conditions prompt individuals to seek treatment for depression, leading to higher prescription rates for antidepressants. Access to healthcare services and insurance coverage significantly impacts patients' ability to afford antidepressant medications, thereby driving GABA supplement market growth.

According to Forbes Health, anxiety disorder ranks among the most prevalent mental health concerns in the United States, affecting approximately 40 million adults annually. Despite its treatability, only around one-third of these individuals receive proper treatment, prompting many to seek alternative remedies such as dietary supplements to address the issue.

What are the Reasons Behind Rising Sales of GABA Supplements in China?

“Rising Demand for Natural and Alternative Remedies for Anxiety-Related Issues”

Attribute	China
Market Value (2024E)	US$ 8.7 Million
Growth Rate (2024 to 2034)	6.5% CAGR
Projected Value (2034F)	US$ 16.4 Million

As mental health and well-being become better understood in China, there is a growing demand for supplements and products believed to promote relaxation and alleviate anxiety. Rising urbanization in the country has led to heightened stress levels and increased anxiety among its population, prompting individuals to seek out GABA supplements as a potential remedy for stress management and relaxation. Successful marketing and promotional efforts by supplement manufacturers are driving the uptick in GABA supplement sales in China.

Companies often emphasize the stress-reducing and anxiety-alleviating properties of GABA through advertising and endorsements. Traditional Chinese Medicine stresses the importance of balance and harmony within the body. GABA supplements align with these principles and are seen as a natural method for restoring balance and promoting relaxation.

Category-wise Insights

Why Do Pharmacies Account for Significant GABA Supplement Market Share?

“Enhanced Accessibility to Pharmacies Facilitating Smooth Purchase of GABA Supplements”

Attribute	Pharmacies
Market Value (2024E)	US$ 18 Million
Market Share (2024E)	34.6%
Projected Value (2034F)	US$ 33 Million

Consumers trust pharmacies as dependable sources of health products. The presence of licensed healthcare professionals enhances confidence in GABA supplements. Pharmacies are easily accessible and conveniently located, facilitating the purchase of GABA supplements and other health items during routine visits.

Pharmacists possess comprehensive knowledge about supplements, including GABA. Their ability to offer tailored recommendations and information influences consumer decisions and boosts sales. Pharmacies prioritize stocking products from reputable manufacturers, ensuring GABA supplements meet stringent quality and regulatory standards, thus attracting consumers seeking safety and efficacy.

Pharmacies often collaborate with healthcare providers, promoting awareness of GABA supplements within holistic health management strategies. Many consumers perceive pharmacy-sourced supplements as superior in quality and reliability, driving a preference for GABA supplements from pharmacies over other retailers.

Why are GABA Supplements in the Form of Gummies Widely Preferred?

“Ease of Consumption Due to its Appealing Form & Flavor”

Attribute	Gummies
Market Value (2024E)	US$ 28 Million
Market Share (2024E)	54.48%
Projected Value (2034F)	US$ 49 Million

Gummies come in various flavors and shapes, making them visually appealing and enjoyable to consume, especially for those who find swallowing pills difficult. Gummies are convenient and require no water or preparation, making them ideal for people on the go or those seeking a quick and effortless way to take supplements.

Gummies appeal to both children and adults, catering to diverse supplement needs within households and expanding the potential consumer base for GABA supplements in gummy form. Marketed as a fun and tasty way to integrate essential nutrients into daily routines, gummies are perceived as a wholesome treat, encouraging consumers to opt for GABA supplements in gummy form over traditional options.

“Adoption of Effective Marketing Strategies to Promote Sales of Gummies”

Companies employ vibrant packaging and targeted marketing to promote GABA supplements in gummy form. This highlights the convenience, taste, and potential advantages of gummies, attracting consumers to this specific product format. With the increasing popularity of functional foods and supplements offering specific health benefits, GABA supplements in gummy form meet this demand by providing consumers with a convenient and enjoyable way to enhance their well-being.

Competitive Landscape

Key players in the GABA supplement industry are Now Foods, Horbaach, Pure Encapsulations, Thorne, Vitanica, Nutrabio, Country Life, and Integrative Therapeutics.

• According to data compiled by Japan-based nutraceutical and cosmetics consultancy firm Smooth Link Inc. for the fiscal year 2021, GABA, a non-proteinogenic amino acid commonly utilized in supplements for stress relief, sleep aid, and blood pressure reduction, emerged as the most favored ingredient across various types of FFCs (functional foods and beverages). Specifically, GABA was present in 78 processed foods, 54 supplements, and 12 fresh foods within the FFC category.

Key Segments of GABA Supplement Market Research

• By Form :

  • Capsules
  • Lozenges
  • Powder
  • Gummies

• By Distribution Channel :

  • Online Stores
  • Pharmacies
  • Supermarkets

• By Region :

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia & Oceania
  • Middle East & Africa (MEA)